Report of Foreign Issuer (6-k)
March 01 2017 - 9:48AM
Edgar (US Regulatory)
FORM
6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington
D.C. 20549
Report
of Foreign Issuer
Pursuant
to Rule 13a-16 or 15d-16 of
the
Securities Exchange Act of 1934
For
period ending
01 March
2017
GlaxoSmithKline
plc
(Name
of registrant)
980
Great West Road, Brentford, Middlesex, TW8 9GS
(Address of
principal executive offices)
Indicate by check
mark whether the registrant files or
will
file annual reports under cover Form 20-F or Form 40-F
Form
20-F x Form 40-F
--
Indicate by check
mark whether the registrant by furnishing the
information
contained in this Form is also thereby furnishing the
information to the
Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange
Act of 1934.
Yes
No x
GlaxoSmithKline
plc
Total
Voting Rights and Capital
In
conformity with Disclosure and Transparency Rule 5.6.1R,
GlaxoSmithKline plc (the 'Company') hereby notifies the market of
the following:
The
Company's issued share capital as at 28 February 2017 consisted of
5,370,130,274 ordinary shares of 25 pence each ('Ordinary Shares'),
of which 453,205,950 Ordinary Shares were held in
Treasury.
Therefore, the
total number of voting rights in the Company is 4,916,924,324. This
figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
Company under the Financial Conduct Authority's Disclosure and
Transparency Rules.
V
A Whyte
Company
Secretary
1 March
2017
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorised.
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: March
01, 2017
|
|
|
|
|
By: VICTORIA
WHYTE
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|
GSK (NYSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GSK (NYSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024